DAPK1 and nonpapillary renal cell carcinoma: Since we observed a close relationship between DAPK1 and metastasis as well as drug resistance in ccRCC patients, we analyzed DAPK1 expression in two sunitinib-resistant cell lines, 786-O-R and ACHN-R [16] by western blotting and immunofluorescence assays.